Biology in prevention and treatment of brain metastases

Area of Science:

• Oncology
• Neuroscience
• Pathobiology

Background:

• Brain metastases are a frequent complication in cancer patients, leading to severe neurocognitive decline and poor prognosis.
• These metastases present unique pathobiological and clinical challenges compared to other metastatic sites.
• Despite their incidence, research into the pathobiology of brain metastases has been historically limited.

Purpose of the Study:

• To highlight the distinct nature of brain metastases.
• To discuss recent advances in understanding their pathobiology.
• To explore emerging therapeutic strategies and preventative measures.

Main Methods:

• Review of current scientific literature on brain metastasis.
• Analysis of pathobiological and clinical differences between brain and other metastases.
• Identification of recently discovered druggable targets and novel treatment approaches.

Main Results:

• Druggable targets have been identified in brain metastases across various tumor types.
• Novel treatment strategies are emerging as viable options for select patients.
• Fundamental aspects of brain metastasis formation are being elucidated, paving the way for prevention.

Conclusions:

• Understanding the unique pathobiology of brain metastases is crucial for developing effective treatments.
• Advances in research are leading to new therapeutic and preventative options for brain metastases.
• Targeted therapies and preventative strategies hold promise for improving outcomes in cancer patients with brain metastases.